BataZu Advanced Therapeutics was proud to participate in the III Conference Looking Today at Tomorrow’s Immunotherapy – Expanding Innovation and Impact, held on 14 March 2026 in Lisbon, Portugal. The meeting convened national and international hematology experts to discuss advances in cellular immunotherapy, including T-cell therapies, CAR-T innovation, treatment accessibility, and real-world clinical experience in Portugal.

BataZu was represented by Mariana Silva, Scientific Board Member, whose invited presentation marked an important contribution to the scientific community by presenting preclinical data on a dual CAR-T approach for acute myeloid leukemia (AML). Her participation highlighted BataZu’s commitment to translational science and next-generation therapeutic innovation.

Organized by APCL, SPH and Associação BataZu, the conference fostered scientific exchange and multidisciplinary dialogue to advance immunotherapy research and clinical impact. It also underscored the value of collaboration across the scientific and clinical community.

To explore the full conference programme, please click here.